Company news
Aptevo Therapeutics Inc. news in 2019
Aptevo Therapeutics Inc.'s news releases, calls and decks from 2019, newest first.
Aptevo Therapeutics Receives Orphan Drug Designation for APVO436 for the Treatment of Acute Myelogenous Leukemia
December 5, 2019
Aptevo Therapeutics Reports Third Quarter 2019 Financial Results
November 6, 2019
Aptevo Therapeutics Introduces New Adaptir™ Bispecific Antibody Candidate Intended for the Treatment of Solid Tumors
September 18, 2019
Aptevo Therapeutics Reports IXINITY® and Pipeline Progress
April 14, 2019
Decks in 2019
- Investor Presentation (January 2019)
Investor deck · 31 slides · Jan 9, 2019